🇺🇸 Pantoprazole Sodium in United States

Pantoprazole Sodium (Pantoprazole Sodium) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pricing & reimbursement

Pantoprazole Sodium in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Gastroenterology approved in United States

Frequently asked questions

Is Pantoprazole Sodium approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pantoprazole Sodium in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does Pantoprazole Sodium cost in United States?

annual_list: USD 43.36 per year. Final patient cost depends on reimbursement and any patient access scheme.